PCT/EP2012/062511

METHODS FOR TREATING IMMUNE-MEDIATED DISEASES OF THE NERVOUS SYSTEM ADMINISTERING A COMPOUND COMPRISING AGENTS THAT INHIBIT PROKINETICIN RECEPTORS ACTIVITY

Details for PCT/EP2012/062511

Application No.

PCT Application Number

PCT/EP/2012/062511

Publication No.

PCT Publication Number

WO/2013/000974

Applicants

PCT Patent Applicants

FONDAZIONE I.R.C.C.S. ISTITUTO NEUROLOGICO "CARLO BESTA"
PEDOTTI, Rosetta
ABOU HAMDAN, Mohamad

Agents

PCT Patent Agents

RAPISARDI, Mariacristina

Priority Data

PCT Patent Priority Data

ITMI2011A001225 filed on June 30, 2011

PCT Pamphlet

The front page of the PCT Patent Application

PCT Pamphlet Front Page

Dates

Application Date

June 27, 2012

Publication Date

January 3, 2013

Earliest Priority Date

June 30, 2011

Deadlines

30 Month Date

30 Month National Phase Deadline.

December 30, 2013

31 Month Date

31 Month National Phase Deadline.

January 30, 2014

These dates are in the Past. Contact us to find out if National Phase entry is still possible.

Abstract

The invention relates to a compound comprising non-peptide prokineticin receptors antagonists and agents that modulate or inhibit the activity of prokineticin receptors for use in the treatment of immune-mediated diseases of the central nervous system, peripheral nervous system and neuromuscular junctions.

Info

PCT Patent application PCT/EP2012/062511 was filed on June 27, 2012 by FONDAZIONE I.R.C.C.S. ISTITUTO NEUROLOGICO "CARLO BESTA"; PEDOTTI, Rosetta; ABOU HAMDAN, Mohamad. The title of this PCT Patent Application is "METHODS FOR TREATING IMMUNE-MEDIATED DISEASES OF THE NERVOUS SYSTEM ADMINISTERING A COMPOUND COMPRISING AGENTS THAT INHIBIT PROKINETICIN RECEPTORS ACTIVITY" and the patent specification was published as WO/2013/000974 on January 3, 2013.

The earliest priority date for the patent application is June 30, 2011 and therefore the 30 month national phase deadline for PCT/EP/2012/062511 is December 30, 2013 and the 31 month national phase deadline for PCT/EP/2012/062511 is January 30, 2014

Legal

The information provided herein is not legal or other professional advice. The information herein may be provided from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein.